|Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial|
DW Andrews, CB Scott, PW Sperduto, AE Flanders, LE Gaspar, ...
The Lancet 363 (9422), 1665-1672, 2004
|A randomized trial of bevacizumab for newly diagnosed glioblastoma|
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
|Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases|
PW Sperduto, N Kased, D Roberge, Z Xu, R Shanley, X Luo, PK Sneed, ...
Journal of Clinical Oncology 30 (4), 419, 2012
|A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database|
PW Sperduto, B Berkey, LE Gaspar, M Mehta, W Curran
International Journal of Radiation Oncology* Biology* Physics 70 (2), 510-514, 2008
|Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group …|
G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ...
J Clin Oncol 24 (18), 2707-2714, 2006
|Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate …|
ME Hegi, L Liu, JG Herman, R Stupp, W Wick, M Weller, MP Mehta, ...
Journal of clinical oncology 26 (25), 4189-4199, 2008
|Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402|
G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ...
Journal of clinical oncology 31 (3), 337, 2013
|Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients|
PW Sperduto, ST Chao, PK Sneed, X Luo, J Suh, D Roberge, A Bhatt, ...
International Journal of Radiation Oncology* Biology* Physics 77 (3), 655-661, 2010
|A multiinstitutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis|
RM Auchter, JP Lamond, E Alexander III, JM Buatti, R Chappell, ...
International Journal of Radiation Oncology* Biology* Physics 35 (1), 27-35, 1996
|Image guidance for precise conformal radiotherapy|
TR Mackie, J Kapatoes, K Ruchala, W Lu, C Wu, G Olivera, L Forrest, ...
International Journal of Radiation Oncology* Biology* Physics 56 (1), 89-105, 2003
|A multi-institutional review of radiosurgery alone vs. radiosurgery with whole brain radiotherapy as the initial management of brain metastases|
PK Sneed, JH Suh, SJ Goetsch, SN Sanghavi, R Chappell, JM Buatti, ...
International Journal of Radiation Oncology* Biology* Physics 53 (3), 519-526, 2002
|Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with …|
L Souhami, W Seiferheld, D Brachman, EB Podgorsak, M Werner-Wasik, ...
International Journal of Radiation Oncology* Biology* Physics 60 (3), 853-860, 2004
|Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial|
MR Gilbert, M Wang, KD Aldape, R Stupp, ME Hegi, KA Jaeckle, ...
Journal of clinical oncology 31 (32), 4085, 2013
TR Mackie, J Balog, K Ruchala, D Shepard, S Aldridge, E Fitchard, ...
Seminars in radiation oncology 9 (1), 108-117, 1999
|Preservation of memory with conformal avoidance of the hippocampal neural stem-cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase II …|
V Gondi, SL Pugh, WA Tome, C Caine, B Corn, A Kanner, H Rowley, ...
Journal of Clinical Oncology 32 (34), 3810, 2014
|Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial|
CA Meyers, JA Smith, A Bezjak, MP Mehta, J Liebmann, T Illidge, ...
Journal of clinical oncology 22 (1), 157-165, 2004
|The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline|
ME Linskey, DW Andrews, AL Asher, SH Burri, D Kondziolka, ...
Journal of neuro-oncology 96 (1), 45-68, 2010
|Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08|
PY Wen, WKA Yung, KR Lamborn, PL Dahia, Y Wang, B Peng, LE Abrey, ...
Clinical Cancer Research 12 (16), 4899-4907, 2006
|Whole-brain radiotherapy in the management of brain metastasis|
D Khuntia, P Brown, J Li, MP Mehta
Journal of Clinical Oncology 24 (8), 1295-1304, 2006
|Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases|
MP Mehta, P Rodrigus, CHJ Terhaard, A Rao, J Suh, W Roa, L Souhami, ...
Journal of Clinical Oncology 21 (13), 2529-2536, 2003